Drug Trial Radar · NCT06571383
STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss
Last checked: Nov 20, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Sep 17, 2024
Primary completion
Nov 15, 2028
Study completion Nov 15, 2031
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Aug 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 15 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is testing how well semaglutide can help adolescents with excess body weight to lose weight and to maintain weight loss. All participants in the study will receive semaglutide as a weekly injection. The study medicine is injected with a thin needle in the stomach, thighs or upper arms. All participants will get semaglutide treatment for a minimum of 3 years.
Conditions
- Obesity
Interventions
SemaglutideDrug
Participants will receive semaglutide s.c(under the skin) once weekly.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maintenance of Body Mass Index (BMI) below obesity thresholdTime frame: From 1.5 years to 3 years
Locations
93 sites in 13 countries. Site status is shown where the registry gives one.
Neighborhood Healthcare
Escondido, California
Clinical Neuroscience Solution
Orlando, Florida
TMH Physician Partners Endo
Tallahassee, Florida
Children's Healthcare Atlanta
Atlanta, Georgia
Columbus Research Foundation
Columbus, Georgia
Eastside Bariatric and Gen Surg
Snellville, Georgia
Solaris Clinical Research
Meridian, Idaho
Synexus Clinical Research US Inc.-Chicago
Chicago, Illinois
Indiana University Hospital
Indianapolis, Indiana
University Of Iowa Hospitals and Clinics
Iowa City, Iowa
Pennington Biom Res Ctr
Baton Rouge, Louisiana
Barry J. Reiner, MD LLC
Baltimore, Maryland
University of Minnesota
Minneapolis, Minnesota
Mississippi CTR for ADV MED
Madison, Mississippi
UBMD Peds-Div of Endo/Diabetes
Buffalo, New York
WakeMed Childn Endo-Dbt_Raleig
Raleigh, North Carolina
Valley Weight Loss Clinic
Fargo, North Dakota
Centricity Research - Ohio
Columbus, Ohio
PriMed Clinical Research
Dayton, Ohio
UPMC Child Hosp-Pittsburgh
Pittsburgh, Pennsylvania
Coastal Carolina Research Ctr
North Charleston, South Carolina
Clinical Neuroscience Solutions
Memphis, Tennessee
Texas Diabetes Institute
San Antonio, Texas
Clinical Trials of Texas Inc
San Antonio, Texas
Health Res of Hampton Roads
Newport News, Virginia
Virginia Commonwealth Univ
Richmond, Virginia
UZ Brussel - Universitair Ziekenhuis Brussel
Brussels, Belgium
Cliniques universitaires Saint-Luc
Brussels, Belgium
UZA - Universitair Ziekenhuis Antwerpen
Edegem, Belgium
Uz Leuven
Leuven, Belgium
Alberta Children's Hospital
Calgary, Alberta, Canada
Stollery Children's Hospital
Edmonton, Alberta, Canada
BC Children's Hospital
Vancouver, British Columbia, Canada
Markham Stouffville Hosp
Markham, Ontario, Canada
The Hospital for Sick Children
Toronto, Ontario, Canada
McMaster Children's Hospital
West Hamilton, Ontario, Canada
Maison de Sante Prevention
Montreal, Quebec, Canada
McGill Uni Health Ctre - Glen Site
Montreal, Quebec, Canada
Aarhus Universitetshospital, Steno Diabetes Center Aarhus
Aarhus, Denmark
Aalborg Universitetshospital - Børne og Ungeafdelingen
Gistrup, Denmark
Showing 40 of 93 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.